Tianshui Zhongxing Bio-technology Co Ltd (002772) - Total Liabilities
Based on the latest financial reports, Tianshui Zhongxing Bio-technology Co Ltd (002772) has total liabilities worth CN¥3.16 Billion CNY (≈ $461.69 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Tianshui Zhongxing Bio-technology Co Ltd (002772) net asset momentum to track the company's year-over-year net asset growth rate.
Tianshui Zhongxing Bio-technology Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Tianshui Zhongxing Bio-technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002772 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Tianshui Zhongxing Bio-technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tianshui Zhongxing Bio-technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wowprime Corp
TW:2727
|
Taiwan | NT$13.51 Billion |
|
Shandong Molong Petroleum Machinery Co Ltd
SHE:002490
|
China | CN¥2.03 Billion |
|
BELL AGROMACHINA ORD T (BSE)
NSE:BALUFORGE
|
India | Rs2.75 Billion |
|
Lotus Technology Inc.
NASDAQ:LOT
|
USA | $3.28 Billion |
|
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020
|
China | CN¥663.27 Million |
|
Nanjing Canatal Data Centre Environmental Tech Co Ltd Class A
SHG:603912
|
China | CN¥2.11 Billion |
|
China Fortune Land Development Co Ltd
SHG:600340
|
China | CN¥259.93 Billion |
|
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404
|
China | CN¥569.21 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Tianshui Zhongxing Bio-technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tianshui Zhongxing Bio-technology Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tianshui Zhongxing Bio-technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tianshui Zhongxing Bio-technology Co Ltd (2011–2024)
The table below shows the annual total liabilities of Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.87 Billion ≈ $420.29 Million |
+8.87% |
| 2023-12-31 | CN¥2.64 Billion ≈ $386.06 Million |
-17.15% |
| 2022-12-31 | CN¥3.18 Billion ≈ $465.99 Million |
-3.51% |
| 2021-12-31 | CN¥3.30 Billion ≈ $482.92 Million |
+15.81% |
| 2020-12-31 | CN¥2.85 Billion ≈ $416.99 Million |
+18.20% |
| 2019-12-31 | CN¥2.41 Billion ≈ $352.77 Million |
+63.24% |
| 2018-12-31 | CN¥1.48 Billion ≈ $216.11 Million |
+1.38% |
| 2017-12-31 | CN¥1.46 Billion ≈ $213.18 Million |
+57.99% |
| 2016-12-31 | CN¥922.12 Million ≈ $134.94 Million |
+43.01% |
| 2015-12-31 | CN¥644.80 Million ≈ $94.36 Million |
+14.51% |
| 2014-12-31 | CN¥563.09 Million ≈ $82.40 Million |
+44.18% |
| 2013-12-31 | CN¥390.55 Million ≈ $57.15 Million |
+87.39% |
| 2012-12-31 | CN¥208.41 Million ≈ $30.50 Million |
+83.26% |
| 2011-12-31 | CN¥113.73 Million ≈ $16.64 Million |
-- |
About Tianshui Zhongxing Bio-technology Co Ltd
Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of edible fungi in China and internationally. It offers flammulina velutipe mushrooms under the Xihuang brand; agaricus bisporus mushrooms under the Zhongxing brand; and cordyceps sinensis mushrooms, as well as packaging boxes for its products. The company also… Read more